Aids infographic Designed for mybiosource to promote Elisa testing.
 
For the US population born after 1981, the blissful ease of youthful innocence in the 1960’s and ‘70’s is something nostalgic and retro. Nearly simultaneously in 1983, Robert Gallo (USA) and Luc Montagnier (FR) identified a unique lentiviral family member - Human Immunodeficiency Virus HIV - responsible for a mysterious epidemic of immune deficiencies, pneumocytic infections and Karposi’s sarcoma among select populations - Acquired ImmunoDeficiency Syndrome AIDS, creating worldwide panic. In the more than 30 years since that fateful discovery, our current knowledge of the origins, transmission, pathology and treatment for initial exposures and active disease have risen dramatically. Whole scientific journals are devoted to Epidemiology or Surveillance and US and European Centers for Disease Control have major centers dedicated specifically to HIV-AIDS work. Yet, rates of transmission remain among particular susceptible groups is alarmingly high. And regions, such as Sub-Saharan Africa, have > 5% of their population living with viral infection, leading to continual transmission throughout local peoples.

Treatments, not cures, are the only possibilities to stave off active disease, once HIV becomes established in patients. Antiretrovirals read like an alphabet soup of drug cocktails, each more powerful and debilitating than the next. Protease inhibitors, integrase strand transfer inhibitors; the list grows but the deaths mount up. A knowledgeable and vigilant population is still the best defense against transmission and infection. Learn your risk and prevention measures. Excellent resources are available through local Public Health departments, the CDC or your physician. - source
Back to Top